Chapter 2 - The Two-Hour Diagnosis

The escape from the house had to look like an everyday mishap. In the theater of family dysfunction, ordinary incompetence was always less suspicious than open confrontation.
Eleanor emerged from the bathroom with a splash of water deliberately soaked across the front of her cardigan. "Marcus, Julianne, I am so sorry," she announced, laughing with high-strung, self-deprecating energy. "I managed to knock my entire cup of tea off the counter, and Lily stepped right in the puddle. Her socks and leggings are completely drenched."
Julianne frowned, setting her fork down with an irritated sigh. "Eleanor, honestly. She has clean clothes in her room."
"Actually," Eleanor said, scooping Lily into her arms before Marcus could intervene, "I promised her earlier that we’d run down to the organic creamery by the village before it closes at eight. Look at her—she’s exhausted, she’s covered in tea, and I promised her a scoop of strawberry. Let me take her for an hour, get her some fresh air, and I’ll buy her a change of clothes at the boutique next door. You two have your dinner in peace."
Marcus looked up from his plate, the steak knife hovering an inch above his meat. His eyes narrowed, calculating the variables. "It's late, El. She hasn't finished her dinner."
"She’s barely touched it anyway," Eleanor pressed, her heart slamming against her throat as she stepped casually toward the front foyer. "Come on, Marcus. I haven't spent an evening with my niece in three months. Give her parents a break for one night."
For three excruciating seconds, the room hung on a knife-edge. Then Julianne sighed, waving a dismissive hand. "Take her. Just don't let her have chocolate; it keeps her awake. And bring her back by nine. She has her developmental therapy session tomorrow morning."
"Nine o'clock sharp," Eleanor promised.
She didn't run to her car, but her stride was brisk, purposeful. She strapped Lily into the booster seat in the back of her Subaru, her hands working the buckles with mechanical speed. The moment she slammed the driver's door and locked it from the inside, she let out a ragged breath that sounded like a sob.
"Auntie El?" Lily asked from the back, her voice small, her eyes reflecting the orange glow of the dashboard lights. "Are we going to get ice cream?"
"We’re going to see a friend of mine first, sweetheart," Eleanor said, shifting into reverse and pulling out of the driveway without looking back at the house, though in her rearview mirror, she saw the silhouette of Marcus standing at the living room window, his phone pressed to his ear. "A friend who has some very special medicine to make your legs stop hurting."
The drive from Oakridge Crest to the private rear entrance of the St. Jude’s Pediatric Annex took twenty-two minutes. Eleanor drove with both hands white-knuckling the steering wheel, running through every pharmacology manual she had ever read.
*BioSynthetix Labs. NEURO-MOD-4B.*
BioSynthetix had spent the last three years publicly touting their research into targeted transdermal therapies for neurodegenerative disorders. Marcus was the project director for their neuro-pharmaceutical division. The press releases had talked about breakthrough treatments for adult ALS and muscular dystrophy.
Why was an unreleased clinical prototype wired into a chair in his home office? And why was his five-year-old daughter the subject?
The private ambulance bay at the rear of the annex was illuminated by cold, blue-tinged LED lights. Dr. Raymond Ruiz was already waiting by the double doors, dressed in surgical scrubs, a tablet tucked under his arm. He was sixty, with silver hair cropped close to his scalp and the calm, unflappable demeanor of a man who had pulled hundreds of children back from the edge of oblivion.
"Bay Four," Ruiz said without greeting, taking Lily gently from Eleanor’s arms the moment she stepped out of the vehicle. "I’ve locked down the wing. No charting under her legal name until we know what we’re dealing with. She's registered as Jane Doe."
"Thank you, Raymond," Eleanor whispered, her knees threatening to buckle as they walked through the sterile, pressurized corridors.
Bay Four was small, isolated, and equipped with a full diagnostic suite. Ruiz laid Lily on the exam table, which was covered in clean, crinkling paper. The child didn't cry. She simply lay there, staring up at the acoustic ceiling tiles with an eerie, practiced detachment that broke Eleanor’s heart.
"Alright, Lily-bug," Eleanor said, stepping to the side of the table and taking the girl’s cold hand. "Dr. Ruiz is just going to look at your legs. He’s going to use a special light, okay? It won't hurt at all."
Ruiz worked with swift, silent efficiency. He unbuttoned Lily’s canvas trousers and slid them down, along with her undergarments.
Eleanor gasped, her hand flying to her mouth.
In the dim light of Marcus’s living room, the damage had been invisible under her clothing. But here, beneath the clinical halogen surgical lamps, Lily’s thighs and lower buttocks told a horrifying story.
The skin was patterned with dozens of tiny, purplish-red geometric clusters. They looked like minute insect bites, perfectly spaced, forming a rectangular grid that corresponded exactly with the dimensions of the micro-filament arrays Eleanor had seen beneath the wingback chair. Surrounding each cluster was a faint halo of indurated, yellowish tissue—localized necrosis and severe subcutaneous inflammation.
"Look at the capillary fragility," Ruiz muttered, his brow furrowing as he pulled a digital dermatoscope from the wall mount. He pressed the lens against Lily’s upper thigh. The image magnified on the wall monitor: tiny, puncture-like lesions, each surrounded by a micro-ring of chemical crystallization. "This isn't an allergic reaction. This is systemic, repetitive puncturing paired with a transdermal solvent."
"I saw the unit, Raymond," Eleanor whispered, her voice shaking with rage. "It's a BioSynthetix prototype. A programmable transdermal delivery array wired into Marcus’s chair. He makes her sit in it for 'discipline.'"
Ruiz’s jaw clenched. "Pull five milliliters of venous blood. Full metabolic panel, heavy metals, synthetic cholinesterase inhibitors, and run an ultra-high performance liquid chromatography screen through the mass spec lab on five. I’ll run it myself."
"What do you think it is?" Eleanor asked, preparing the butterfly needle with hands that were finally steady, driven by pure, clinical survival instinct.
"Look at her reflexes," Ruiz said, tapping Lily’s patellar tendon with a small rubber hammer.
There was no response. The child’s lower leg remained completely limp.
"Areflexia in the lower extremities," Ruiz said grimly. "Mild ptosis in her left eyelid. Slow pupillary response. Eleanor... whatever is in those vials, it’s a targeted neuromuscular blocking agent. A synthetic peptide designed to suppress peripheral nerve conduction."
"A paralytic?" Eleanor felt sick. "He’s paralyzing her?"
"Not completely. Low-dose, sustained administration. Enough to cause progressive muscular weakness, lethargy, sensory ataxia, and chronic pain, without causing full respiratory failure." Ruiz adjusted his glasses, his face dark with fury. "If a doctor saw these symptoms without knowing about the chair, what would the diagnosis be?"
Eleanor stared at him, the horrifying truth dawning in her mind like cold water seeping into a basement. "Early-onset spinal muscular atrophy. Or a progressive hereditary myopathy."
"Precisely," Ruiz said. "An idiopathic, untreatable degenerative disorder. A tragic, slow decline."
"Why?" Eleanor cried out, unable to contain the agony in her voice. "Why would a father do this to his own child?"
"We’re going to find out," Ruiz said, taking the blood vials from her hands. "Keep her here. Keep the door locked. I’ll have the initial mass spec results in sixty minutes."
While Ruiz was in the toxicological lab, Eleanor stayed by Lily’s side, washing the chemical residue from her skin with sterile saline and wrapping her small, bruised legs in soft, cooling hydrogel bandages. Lily had drifted into a heavy, unnatural sleep, her breathing shallow and rhythmic.
Fifty minutes later, the door to Bay Four slid open.
Ruiz did not look triumphant. He looked shaken, his face pale beneath his grey stubble. He held a sheaf of printouts and a plastic evidence bag containing a printout of a genetic marker profile.
"The compound is a modified analogue of vecuronium, conjugated with a synthetic lipid carrier to allow transdermal absorption," Ruiz said, his voice low and dangerous. "It’s proprietary. It has BioSynthetix’s molecular signature stamped all over it."
"We call the FBI," Eleanor said immediately, reaching for her phone. "We take this to the feds right now."
"Wait, Eleanor," Ruiz said, holding up a hand. "That's only half of what the lab found."
"What do you mean?"
"I ran her DNA through the state registry’s pediatric rare-disease database to see if Marcus had already filed for experimental drug exemptions under her profile," Ruiz said, leaning against the counter. "The system pulled her newborn screening profile from five years ago. Eleanor... Lily isn't Julianne’s child."
Eleanor blinked, the room tilting slightly. "What? Of course she is. Julianne was pregnant. We had a baby shower—"
"Julianne had a surrogate pregnancy that was terminated at twenty-four weeks due to severe complications at a private clinic in Zurich," Ruiz said, tapping the paper. "Lily’s maternal DNA doesn't match Julianne at all. And it doesn't match Marcus either."
Eleanor felt the air leave her lungs. "She’s... she’s not their daughter?"
"Biologically? Not even remotely," Ruiz whispered. "Her maternal markers belong to a woman named Clara Van Doren. And Clara Van Doren isn't just an anonymous donor, Eleanor. She was the sole heiress to the Van Doren maritime shipping estate. She disappeared six years ago, presumed drowned in a private sailing accident off the coast of Rhode Island. And according to the probate records filed three years ago, Clara’s entire fourteen-million-dollar trust fund was placed under the guardianship of BioSynthetix’s clinical research division... to be held in trust for any surviving biological issue."
The horror settled into Eleanor’s marrow.
Lily wasn't their daughter. She was an asset. A stolen child, kept sick and compliant, her body turned into an annuity to drain a multi-million-dollar trust fund under the guise of round-the-clock palliative medical care.
And then, Eleanor’s phone began to vibrate violently against the steel counter.
The screen lit up with an incoming video call.
May you like
The caller ID read: **MARCUS**.
---